This week's roundup of Houston innovators includes Craig Ceccanti of T-Minus Solutions, Katie Eick of Rockin' Pets, Rollin' Vets, and Blair Garrou of Mercury. Photos courtesy

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from venture capital to software — recently making headlines in Houston innovation.


Craig Ceccanti, founder and CEO of T-Minus Solutions

Words of wisdom from a founder who's done this all before. And then again. And again. Photo courtesy of T-Minus Solutions

After starting a company or two — or three — Craig Ceccanti has some observations on his own entrepreneurial journey. He also has some hard lessons learned, and he shared four of them in a guest column for InnovationMap.

"I’m not immune to making mistakes," he writes. "As a serial entrepreneur and having started, led, and mentored various successful companies, I have made some mistakes and have been lucky enough to learn from them."Read more.

Katie Eick, founder and CEO of Rockin' Pets, Rollin' Vets

Katie Eick, founder and CEO of Rockin' Pets Rollin' Vets joins the Houston Innovators Podcast to discuss her company's growth. Photo courtesy of Rollin' Vets

For years, Dr. Katie Eick wanted to provide mobile veterinary care for her patients, but the technology wasn't where it needed to be. She took a gamble and bought her first truck in 2016 as ridesharing and mobile ordering took off. A new business of convenience was booming, before blasting off again amid the pandemic.

Now, the founder and CEO of Rockin' Pets, Rollin' Vets says she's got the equipment, the market demand, and a $5 million round of investment to expand her business model.

The other challenge Eick says she faced early on was a misconception that mobile vet care was limited to vaccinations.

"We provide the highest level of veterinary care — right in your driveway," Eick says on this week's episode of the Houston Innovators Podcast, explaining how each of her trucks — she now has five — have the capability to provide all sorts of treatment. Read more.

Blair Garrou, founder and managing partner of Mercury

Blair Garrou will be recognized as the 2022 Trailblazer Award recipient at the Houston Innovation Awards Gala on November 9. Photo courtesy

The name Blair Garrou is quite familiar to most within Houston's startup and innovation ecosystem. As co-founder of Mercury, which launched in 2005, he's seen the city's tech world expand tenfold.

"Although we are in the midst of a recession, Houston continues to grow in three key industrial sectors of innovation – EnergyTech/ClimateTech, HealthTech, and SpaceTech. Our city has the opportunity to be a national leader in each of these sectors, and drive tremendous job growth in the future," he tells InnovationMap.

Garrou was nominated and selected by a group of judges to be the 2022 Trailblazer Award recipient, and will be honored at the Houston Innovation Awards Gala on November 9. Read more.

Katie Eick, founder and CEO of Rockin' Pets Rollin' Vets joins the Houston Innovators Podcast to discuss her company's growth. Photo courtesy of Rollin' Vets

Houston innovator grows mobile vet clinic amid growing industry challenges

HOUSTON INNOVATORS PODCAST EPISODE 156

For years, Dr. Katie Eick wanted to provide mobile veterinary care for her patients, but the technology wasn't where it needed to be. She took a gamble and bought her first truck in 2016 as ridesharing and mobile ordering took off. A new business of convenience was booming, before blasting off again amid the pandemic.

Now, the founder and CEO of Rockin' Pets, Rollin' Vets says she's got the equipment, the market demand, and a $5 million round of investment to expand her business model.

The other challenge Eick says she faced early on was a misconception that mobile vet care was limited to vaccinations.

"We provide the highest level of veterinary care — right in your driveway," Eick says on this week's episode of the Houston Innovators Podcast, explaining how each of her trucks — she now has five — have the capability to provide all sorts of treatment.

"We have a surgery suite, we have high-speed dental equipment — just like your dentist has. We have X-ray machines and ultrasound machines on almost all of our trucks," she explains. "We carry a full pharmacy on every truck."

It took a while to get to where she is today, which is caring for clients across Houston, with a recent expansion into The Woodlands and a soft launch in Austin. She plans to expand in Central Texas, including San Antonio, before tackling the northern region of the state. She also has a franchise model that she hopes to utilize to grow the brand nationally and even abroad.

"It was hard to educate the public on what we can do on those trucks," Eick adds "It took the first year, and once the word started to get out, then it snowballed."

Contributing to the snowball effect was the pandemic, which led pet owners to looking into alternative ways to access vet treatment. Now, Eick is focused on growing her team to support the company's growth. And, she adds, this is no easy task in today's employment climate.

"In this day and age, everyone has a shortage. ... The workforce is just smaller," Eick says. "There's a nationwide shortage of vets, and it's a confluence of things that have happened that I wished we saw coming."

Eick explains how the level of care vets are now able to — and expected to — give has increased with new technologies, specialist practices, and more. But the number of new vets with each graduating class has remained the same. Retention is also an issue, as the toll on veterinarians' mental health takes providing such frequent end of life care — on top of an increasingly busier schedule.

Eick shares more on the show about her observations on the current challenges within the industry as well as how she's innovating within her own practice to combat these obstacles. Listen to the interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.


This week's roundup of Houston innovators includes Enrique Gomez of Texas Medical Center Innovation, Katie Eick of Rockin' Pets Rollin' Vets, and Jim Gable of Chevron. Courtesy photos

3 Houston innovators to know this week

who's who

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from health care innovation to energy — recently making headlines in Houston innovation.

Enrique Gomez, entrepreneur in residence at Texas Medical Center Innovation

Enrique Gomez joins the Houston Innovators Podcast to discuss Houston as an oncology innovation hub. Photo via TMC.edu

When it comes to leading oncology innovation, Houston has a seat at the table, Enrique Gomez, entrepreneur in residence at Texas Medical Center Innovation's Accelerator for Cancer Therapeutics, says on the Houston Innovators Podcast.

"Houston is a place where everyone looks at when it comes to novel research and approaches to treating cancer," Gomez says. "The landscape here is going to be accelerated because we see much more collaboration between the founding institutions — and that's a very important element of growth. Houston has no comparison to any other place in terms of what's going on here and the level and quality of research."Click here to read more and stream the episode.

Katie Eick, founder of Rollin' Vets

Katie Eick always wanted to be able to offer mobile services. Photo courtesy of Rollin' Vets

Houston-based Rockin' Pets, Rollin' Vets, a full-service mobile veterinary clinic based in Houston, has closed a $5 million equity raise with plans to expand across the Lone Star State. Founded by Dr. Katie Eick, who is the company's CEO, Rollin’ Vets Group flips the switch on pet health care by bringing vets to its patients' homes.

This fresh funding helps Eick take that first step toward expansion. According to a news release, Rockin’ Pets, Rollin’ Vets expects to have a presence in Dallas and Austin by March of next year.

“This equity raise allows us to not only hire additional talent, but also increase our mobile clinic fleet, while expanding into other cities at an expedited rate. There is a vast opportunity to serve animals and people that need non-traditional veterinary care in other Texas markets. We are ready to tap into these markets and bring convenient, state-of-the-art care straight to pet owners’ doorsteps,” says Eick in the release. Click here to read more.

Jim Gable, incoming vice president of innovation and president of Chevron Technology Ventures

Barbara Burger has led Chevron's innovation efforts for almost a decade and is passing the responsibilities to Jim Gable. Photo courtesy

Barbara Burger, vice president of innovation at Chevron and president of Chevron Technology Ventures, is retiring, and passing the role to Jim Gable.

Gable brings his 23 years of experience to the role. Based in Chevron's office on the West Coast, he will be relocating to Houston, per the release. He currently oversees the development and deployment of downstream-related technology for Chevron.

“CTV has a 22-year history of investing in startups across a wide cross section of energy innovation and a track record of collaboration to bring innovation to scale,” Bonner continues. “Jim’s experience at Chevron is deep and diverse. Combined with his technology commercialization experience with CTV early in his career, as well as in his current role, Jim is poised to lead CTV to even greater success.” Click here to read more.

You'll paw-bably soon be seeing Rockin' Pets, Rollin' Vets vans across the Lone Star State. Photo courtesy of Rockin' Pets, Rollin' Vets

Houston mobile vet startup raises $5M to expand statewide

rollin' across texas

An innovative Houston company has closed a fresh round of funding in hopes of rolling its service out statewide.

Rockin' Pets, Rollin' Vets, a full-service mobile veterinary clinic based in Houston, has closed a $5 million equity raise with plans to expand across the Lone Star State. Founded by Dr. Katie Eick, who is the company's CEO, Rollin’ Vets Group flips the switch on pet health care by bringing vets to its patients' homes.

This fresh funding helps Eick take that first step toward expansion. According to a news release, Rockin’ Pets, Rollin’ Vets expects to have a presence in Dallas and Austin by March of next year.

“This equity raise allows us to not only hire additional talent, but also increase our mobile clinic fleet, while expanding into other cities at an expedited rate. There is a vast opportunity to serve animals and people that need non-traditional veterinary care in other Texas markets. We are ready to tap into these markets and bring convenient, state-of-the-art care straight to pet owners’ doorsteps,” says Eick in the release.

Currently, the company has five mobile units staffed by seven veterinarians and 12 skilled veterinary technicians. The company’s capabilities include wellness and illness exams, in-house labs, radiology, end-of-life care, routine surgeries, laser therapy and dental procedures — all within the Greater Houston area. The service plans to expand into The Woodlands in January.

Last year, the company raised $1 million in angel investment and crowdfunding on NextSeed. Patrick Lewis, CFO for Rollin’ Vets Group, says in the release that the capital was raised by a number of individuals, many of whom had prior investments in the pet care industry.

Eick founded her company in 2015 and was seeing steady growth as delivery and on-demand services like Uber, DoorDash, etc. increased in use and awareness of mobile services. Eick previously told InnovationMap that the pandemic really cemented the efficacy of mobile services.

While the company is focused on a Texas expansion for now, it's been in Eick's plan to expand even more broadly for a while.

"We're aiming to be a nationwide brand," Eick previously told InnovationMap.

Katie Eick always wanted to be able to offer mobile services.Photo courtesy of Rollin' Vets

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researchers: Here's what it takes to spot a great new idea

houston voices

Having a “promotion focus” really does create a mental lens through which new ideas are more visible.

Key findings:

  • New ideas can be crucially important to businesses, driving innovation and preventing stagnation.
  • Recognizing those ideas, though, isn’t always easy.
  • Nurturing what is known as “promotion focus” can help managers spot fresh ideas.

Whenever the late surgeon Michael DeBakey opened a human chest, he drew on a lifetime of resources: the conviction that heart surgery could and should be vastly improved, the skill to venture beyond medicine’s known horizons and the vision to recognize new ideas in everyone around him, no matter how little formal training they had.

Appreciating new ideas is the heartbeat of business as well as medicine. But innovation is surprisingly hard to recognize. In a pioneering 2017 article, Rice Business Professor Jing Zhou and her colleagues published their findings on the first-ever study of the traits and environments that allow leaders to recognize new ideas.

Recent decades have produced a surge of research looking at how and when employees generate fresh ideas. But almost nothing has been written on another crucial part of workplace creativity: a leader’s ability to appreciate new thinking when she sees it.

Novelty, after all, is what drives company differentiation and competitiveness. Work that springs from new concepts sparks more investigation than work based on worn, already established thought. Companies invest millions to recruit and pay star creatives.

Yet not every leader can spot a fresh idea, and not every workplace brings out that kind of discernment. In four separate studies, Zhou and her coauthors examined exactly what it takes to see a glittering new idea wherever it appears. Their work sets the stage for an entirely new field of future research.

First, though, the team had to define their key terms. “Novelty recognition” is the ability to spot a new idea when someone else presents it. “Promotion focus,” previous research has shown, is a comfort level with new experiences that evokes feelings of adventure and excitement. “Prevention focus” is the opposite trait: the tendency to associate new ideas with danger, and respond to them with caution.

But does having “promotion focus” as opposed to “prevention focus” color the ability to see novelty? To find out, Zhou’s team came up with an ingenious test, artificially inducing these two perspectives through a series of exercises. First, they told 92 undergraduate participants that they would be asked to perform a set of unrelated tasks. Then the subjects guided a fictional mouse through two pencil and paper maze exercises.

While one exercise showed a piece of cheese awaiting the mouse at the end of the maze (the promise of a reward), the other maze depicted a menacing owl nearby (motivation to flee).

Once the participants had traced their way through the mazes with pencils, they were asked to rate the novelty of 33 pictures — nine drawings of space aliens and 24 unrelated images. The students who were prepped to feel an adventurous promotion focus by seeking a reward were much better at spotting the new or different details among these images than the students who’d been cued to have a prevention focus by fleeing a threat.

The conclusion: a promotion focus really does create a mental lens through which new ideas are more visible.

Zhou’s team followed this study with three additional studies, including one that surveyed 44 human resource managers from a variety of companies. For this study, independent coders rated the mission statements of each firm, assessing their cultures as “innovative” or “not innovative.” The HR managers then evaluated a set of written practices — three that had been in use for years, and three new ones that relied on recent technology. The managers from the innovative companies were much better at rating the new HR practices for novelty and creativity. To recognize novelty, in other words, both interior and external environments make a difference.

The implications of the research are groundbreaking. The first ever done on this subject, it opens up a completely new research field with profound questions. Can promotion focus be created? How much of this trait is genetic, and how much based on natural temperament, culture, environment and life experience? Should promotion focus be cultivated in education? If so, what would be the impact? After all, there are important uses for prevention focus, such as corporate security and compliance. Meanwhile, how can workplaces be organized to bring out the best in both kinds of focus?

Leaders eager to put Zhou’s findings to use right away, meanwhile, might look to the real-world model of Michael DeBakey. Practice viewing new ideas as adventures, seek workplaces that actively push innovation and, above all, cultivate the view that every coworker, high or low, is a potential source of glittering new ideas.

---

This article originally appeared on Rice Business Wisdom.

Jing Zhou is the Mary Gibbs Jones Professor of Management and Psychology in Organizational Behavior at the Jones Graduate School of Business of Rice University. Zhou, J., Wang, X., Song, J., & Wu, J. (2017). "Is it new? Personal and contextual influences on perceptions of novelty and creativity." Journal of Applied Psychology, 102(2): 180-202.

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”